Document is current
Any future updates will be listed below
-
Authors
Stanski, Natalja L. https://orcid.org/0000-0003-4473-8376
Rodrigues, Camila E. https://orcid.org/0000-0003-0562-0893
Strader, Michael https://orcid.org/0000-0002-5089-8539
Murray, Patrick T. https://orcid.org/0000-0001-8516-1839
Endre, Zoltan H.
Bagshaw, Sean M. https://orcid.org/0000-0003-3633-6596
- License Information
-
More Information
Article History
Received: 19 April 2023
Accepted: 12 July 2023
First Online: 8 August 2023
Declarations
:
: SMB disclosed fees for scientific advisory from Baxter, Novartis, Sea Star Medical, BioPorto and SphingoTec. PTM disclosed fees for clinical trial consultancy (Alexion), scientific advisory board (Renibus Therepeutics) or clinical trial steering committee membership (AM-Pharma, Novartis). ZHE disclosed assay support from SphingoTec and scientific advisory board membership (Vifor Pharmaceuticals).
